Skip to main content
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1975 Nov;38(11):1100–1103. doi: 10.1136/jnnp.38.11.1100

Leigh's disease: significance of the biochemical changes in brain.

J V Murphy, L Craig
PMCID: PMC492163  PMID: 1206418

Abstract

Analysis of five brains from patients with Leigh's disease demonstrates an accumulation of thiamine pyrophosphate and a deficiency of thiamine triphosphate. The enzyme which converts thiamine pyrophosphate to thiamine triphosphate was normally active in two of these brains, suggesting that the inhibitor found in Leigh's disease is probably producing the observed neurochemical changes. Reasons for the histological similarity between Leigh's and Wernicke's diseases are suggested.

Full text

PDF
1100

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cooper J. R., Itokawa Y., Pincus J. H. Thiamine triphosphate deficiency in subacute necrotizing encephalomyelopathy. Science. 1969 Apr 4;164(3875):74–75. doi: 10.1126/science.164.3875.74. [DOI] [PubMed] [Google Scholar]
  2. Cooper J. R., Pincus J. H. Role of thiamine triphosphate in subacute necrotizing encephalomyelopathy. J Agric Food Chem. 1972 May-Jun;20(3):490–493. doi: 10.1021/jf60181a002. [DOI] [PubMed] [Google Scholar]
  3. Grover W. D., Auerbach V. H., Patel M. S. Biochemical studies and therapy in subacute necrotizing encephalomyelopathy (Leigh's syndrome). J Pediatr. 1972 Jul;81(1):39–44. doi: 10.1016/s0022-3476(72)80371-8. [DOI] [PubMed] [Google Scholar]
  4. Hommes F. A., Polman H. A., Reerink J. D. Leigh's encephalomyelopathy: an inborn error of gluconeogenesis. Arch Dis Child. 1968 Aug;43(230):423–426. doi: 10.1136/adc.43.230.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Itokawa Y., Cooper J. R. Ion movements and thiamine. II. The release of the vitamin from membrane fragments. Biochim Biophys Acta. 1970;196(2):274–284. doi: 10.1016/0005-2736(70)90015-5. [DOI] [PubMed] [Google Scholar]
  6. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  7. Montpetit V. J., Andermann F., Carpenter S., Fawcett J. S., Zborowska-Sluis D., Giberson H. R. Subacute necrotizing encephalomyelopathy. A review and a study of two families. Brain. 1971;94(1):1–30. doi: 10.1093/brain/94.1.1. [DOI] [PubMed] [Google Scholar]
  8. Murphy J. V. Efficacy of recommended therapeutic regimens in Leigh's disease. Dev Med Child Neurol. 1974 Jun;16(3):362–364. doi: 10.1111/j.1469-8749.1974.tb03348.x. [DOI] [PubMed] [Google Scholar]
  9. Murphy J. V. Subacute necrotizing encephalomyelopathy (Leigh's disease): detection of the heterozygous carrier state. Pediatrics. 1973 Apr;51(4):710–715. [PubMed] [Google Scholar]
  10. Pincus J. H. Subacute necrotizing encephalomyelopathy (Leigh's disease): a consideration of clinical features and etiology. Dev Med Child Neurol. 1972 Feb;14(1):87–101. doi: 10.1111/j.1469-8749.1972.tb02563.x. [DOI] [PubMed] [Google Scholar]
  11. Tang T. T., Good T. A., Dyken P. R., Johnsen S. D., McCreadie S. R., Sy S. T., Lardy H. A., Rudolph F. B. Pathogenesis of Leigh's encephalomyelopathy. J Pediatr. 1972 Jul;81(1):189–190. doi: 10.1016/s0022-3476(72)80428-1. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES